# Eric F. Morand

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/eric-f-morand/

## Facts

| Field | Value |
| --- | --- |
| Citations | 22,427 |
| Field | Systemic Lupus Erythematosus Research |
| h-index | 75 |
| i10-index | 283 |
| Last Known Institution | Novartis (Switzerland) |
| OpenAlex ID | https://openalex.org/A5036855659 |
| ORCID iD | https://orcid.org/0000-0002-9507-3338 |
| Works | 606 |

## Researcher papers

- [Trial of Anifrolumab in Active Systemic Lupus Erythematosus](https://scholariq.org/papers/trial-of-anifrolumab-in-active-systemic-lupus-erythematosus/)
- [EULAR recommendations for the management of systemic lupus erythematosus: 2023 update](https://scholariq.org/papers/eular-recommendations-for-the-management-of-systemic-lupus-erythematosus-2023/)
- [Definition and initial validation of a Lupus Low Disease Activity State (LLDAS)](https://scholariq.org/papers/definition-and-initial-validation-of-a-lupus-low-disease-activity-state-lldas/)
- [Treat-to-target in systemic lupus erythematosus: recommendations from an international task force](https://scholariq.org/papers/treat-to-target-in-systemic-lupus-erythematosus-recommendations-from-an/)
- [2021 DORIS definition of remission in SLE: final recommendations from an international task force](https://scholariq.org/papers/2021-doris-definition-of-remission-in-sle-final-recommendations-from-an/)
- [A framework for remission in SLE: consensus findings from a large international task force on definitions of remission in SLE (DORIS)](https://scholariq.org/papers/a-framework-for-remission-in-sle-consensus-findings-from-a-large-international/)
- [Lupus low disease activity state as a treatment endpoint for systemic lupus erythematosus: a prospective validation study](https://scholariq.org/papers/lupus-low-disease-activity-state-as-a-treatment-endpoint-for-systemic-lupus/)

## Researcher topics

- [Systemic Lupus Erythematosus Research](https://scholariq.org/topics/systemic-lupus-erythematosus-research/)
- [Rheumatoid Arthritis Research and Therapies](https://scholariq.org/topics/rheumatoid-arthritis-research-and-therapies/)
- [Macrophage Migration Inhibitory Factor](https://scholariq.org/topics/macrophage-migration-inhibitory-factor/)
- [Monoclonal and Polyclonal Antibodies Research](https://scholariq.org/topics/monoclonal-and-polyclonal-antibodies-research/)
- [Cytokine Signaling Pathways and Interactions](https://scholariq.org/topics/cytokine-signaling-pathways-and-interactions/)

## Researcher university

- [Novartis (Switzerland)](https://scholariq.org/institutions/novartis-switzerland/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.